J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Rangering i aksjer
#3893
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Aksjekurs
$26.58
Sist synkronisert: 2026-07-23
Markedsverdi
$4.24B
Endring (1 dag)
0.00%
Endring (1 år)
38.40%
Land
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Kategori
Healthcare
Antall utestående aksjer for J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Antall utestående aksjer per March 2026: 159.64M
Ifølge J. B. Chemicals & Pharmaceuticals Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 159.64M. Ved slutten av March 2024 hadde selskapet 154.95M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM) fra 2005 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 159.64M | 0.59% |
| 2025 | 158.71M | 2.42% |
| 2024 | 154.95M | 0.20% |
| 2023 | 154.65M | 100.00% |
| 2022 | 77.32M | 0.05% |
| 2021 | 77.29M | -1.88% |
| 2020 | 78.77M | -4.16% |
| 2019 | 82.19M | -2.12% |
| 2018 | 83.97M | -1.01% |
| 2017 | 84.82M | 0.00% |
| 2016 | 84.82M | 0.04% |
| 2015 | 84.78M | 0.08% |
| 2014 | 84.72M | 0.01% |
| 2013 | 84.71M | 0.10% |
| 2012 | 84.62M | 0.23% |
| 2011 | 84.43M | 0.12% |
| 2010 | 84.33M | 0.00% |
| 2009 | 84.33M | 0.00% |
| 2008 | 84.33M | 0.18% |
| 2007 | 84.17M | 4.74% |
| 2006 | 80.36M | 0.00% |
| 2005 | 80.36M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,402.98% |
IN
|
